Flo Health
Seedtable Score
60
Startups
3
Funding Rounds
3
Investors
$257.5m
Money raised
Overview
Flo Health differentiates itself in the health tech market by offering AI-driven personalized insights tailored to women's reproductive health, addressing a significant industry gap. Unlike general health apps or traditional consultations, Flo provides a comprehensive and convenient solution for tracking and managing reproductive health through its freemium B2C model. This approach offers users more personalized and timely information than manual tracking or standard healthcare consultations. Backed by investors like Target Global and VNV Global and based in London, Flo Health is well-positioned for growth. Its AI-based approach to women’s health needs could lead to higher user engagement and retention, solidifying its competitive edge.
- Website: https://flo.health
- Business model: b2c, freemium
- Company size: 251 - 501 employees
- Headquarters: London, UK
- Founded: 2016
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (3)
Funding
Funding series
Funding Series Analysis
The company Flo Health has raised a total of $257.5m in funding over 3 rounds.
Key Insights:
- Series C: $200m
- Series B: $50m
- Series A: $7.5m
Flo Health Series A (2019, $7M)
$7.5m
Flo Health Series B (2021, $50M)
$50m
Flo Health Series C (2024, $200M)
$200m